Mutations in Two Genes Encoding Different Subunits of a Receptor Signaling Complex Result in an Identical Disease Phenotype
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL), also known as "Nasu-Hakola disease," is a globally distributed recessively inherited disease leading to death during the 5th decade of life and is characterized by early-onset progressive dementia and bone cysts. Elsewhere, we have identified PLOSL mutations in TYROBP (DAP12), which codes for a membrane receptor component in natural-killer and myeloid cells, and also have identified genetic heterogeneity in PLOSL, with some patients carrying no mutations in TYROBP. Here we complete the molecular pathology of PLOSL by identifying TREM2 as the second PLOSL gene. TREM2 forms a receptor signaling complex with TYROBP and triggers activation of the immune responses in macrophages and dendritic cells. Patients with PLOSL have no defects in cell-mediated immunity, suggesting a remarkable capacity of the human immune system to compensate for the inactive TYROBP-mediated activation pathway. Our data imply that the TYROBP-mediated signaling pathway plays a significant role in human brain and bone tissue and provide an interesting example of how mutations in two different subunits of a multisubunit receptor complex result in an identical human disease phenotype.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Homozygous loss-of-function mutations in TREM2 or DAP12 genes cause Nasu–Hakola disease (NHD), a rare genetic disorder characterized by fatal presenile dementia and bone cysts [38, 39].”
From TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis (2020) · cites this paper as [39]
In the citing paper
“TYROBP is a transmembrane adaptor protein for TREM2, SIRPβ1, and CR3 receptors, which are known to be involved in AD pathogenesis [90–92].”
From Sex-specific DNA methylation differences in Alzheimer’s disease pathology (2021) · cites this paper as [92]
In the citing paper
“Homozygous Q33X, Y38C and T66M variants have been identified in patients with Nasu-Hakola disease [44, 47, 95].”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [95]
In the citing paper
“A number of mutations in PLCG2 (about 75%), that have been previously implicated in various inflammatory diseases [92–102], actually map to the autoinhibitory interface on the PLCγ2 model structure and can be considered as pathogenic (Fig. 2c)”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [95]
In the citing paper
“Even more rare loss-of-function mutations of TREM2 or DAP12 cause a form of recessively inherited presenile dementia, called Nasu-Hakola disease (126, 127).”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [126]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Bouchon, A., Dietrich, J., & Colonna, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.4991 · Cited by 1,284 · cited 4×
“2001a), whereas TREM2 is expressed on macrophages and monocyte-derived dendritic cells, suggesting that TREM2 plays a role in chronic, rather than in acute, inflammation (Bouchon et al. 2000).”
BackgroundInfluentialTREM-1 amplifies inflammation and is a crucial mediator of septic shock
Bouchon, A., Facchetti, F., Weigand, M. A., & Colonna, M. (2001) · Nature · doi:10.1038/35074114 · Cited by 1,090 · cited 2×
“TREM1 is strongly up-regulated in cells that mediate acute inflammatory responses to bacterial infection (i.e., neutrophils and monocytes) (Bouchon et al. 2001a), whereas TREM2 is expressed on macrophages and monocyte-derived dendritic cells, suggesting that TREM2 plays a role in chronic, rather…”
BackgroundImmunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells
Lanier, L. L., Corliss, B. C., Wu, J., Leong, C., & Phillips, J. H. (1998) · Nature · doi:10.1038/35642 · Cited by 904 · cited 5×
“This has been shown to disrupt the association with (McVicar et al. 1998; Bakker et al. 1999), as well as the cell-surface expression of, TYROBP (Lanier et al. 1998b; Smith et al. 1998).”
BackgroundInfluentialVitale, M., Bottino, C., Sivori, S., Sanseverino, L., Castriconi, R., Marcenaro, E., Augugliaro, R., Moretta, L., & Moretta, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.2065 · Cited by 748 · cited 1×
“1) (Vitale et al. 1998), MDL1 (chromosome 7q33) (Bakker et al. 1999), CD94 (chromosome 12p13.”
Association of DAP12 with Activating CD94/NKG2C NK Cell Receptors
Lanier, L. L., Corliss, B., Wu, J., & Phillips, J. H. (1998) · Immunity · doi:10.1016/s1074-7613(00)80574-9 · Cited by 559 · cited 5×
“This has been shown to disrupt the association with (McVicar et al. 1998; Bakker et al. 1999), as well as the cell-surface expression of, TYROBP (Lanier et al. 1998b; Smith et al. 1998).”
BackgroundInfluentialLoss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts
Paloneva, J., Kestilä, M., Wu, J., Salminen, A., Böhling, T., Ruotsalainen, V., Hakola, P., Bakker, A. B. H., Phillips, J. H., Pekkarinen, P., et al. (2000) · Nature Genetics · doi:10.1038/77153 · Cited by 460 · cited 6×
“Interestingly, patients with PLOSL who are homozygous for mutations in either TREM2 or TYROBP display identical CNS and bone manifestations (table 2)—and no immunological symptoms (Paloneva et al. 2000).”
BackgroundInfluentialSelf-citationBouchon, A., Hernández-Munain, C., Cella, M., & Colonna, M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.8.1111 · Cited by 460 · cited 2×
“TREM1 is strongly up-regulated in cells that mediate acute inflammatory responses to bacterial infection (i.e., neutrophils and monocytes) (Bouchon et al. 2001a), whereas TREM2 is expressed on macrophages and monocyte-derived dendritic cells, suggesting that TREM2 plays a role in chronic, rather…”
BackgroundLy-49D and Ly-49H associate with mouse DAP12 and form activating receptors.
Smith, K. M., Wu, J., Bakker, A. B. H., Phillips, J. H., & Lanier, L. L. (1998) · PubMed · Cited by 277
Cutting Edge: Ly-49D and Ly-49H Associate with Mouse DAP12 and Form Activating Receptors
Smith, K. M., Wu, J., Bakker, A. B. H., Phillips, J. H., & Lanier, L. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.1.7 · Cited by 249 · cited 1×
“This has been shown to disrupt the association with (McVicar et al. 1998; Bakker et al. 1999), as well as the cell-surface expression of, TYROBP (Lanier et al. 1998b; Smith et al. 1998).”
BackgroundMutations in PATCHED-1, the receptor for SONIC HEDGEHOG, are associated with holoprosencephaly
Ming, J. E., Kaupas, M. E., Roessler, E., Brunner, H. G., Golabi, M., Tekin, M., Stratton, R. F., Sujansky, E., Bale, S. J., & Muenke, M. (2002) · Human Genetics · doi:10.1007/s00439-002-0695-5 · Cited by 244
Research works printed but not linked: 1
- Tranebjærg, 2000, Polycystic lipomembranous osteodysplasia, Tidsskr Nor Laegeforen, 120, 3196
Cited by
Items 401–500 of 694
Genetics of Alzheimer’s disease
König, T., & Stögmann, E. (2021) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-021-00819-9 · Cited by 37
The immunoreceptor adapter protein DAP12 suppresses B lymphocyte–driven adaptive immune responses
Nakano-Yokomizo, T., Tahara‐Hanaoka, S., Nakahashi-Oda, C., Nabekura, T., Tchao, N. K., Kadosaki, M., Totsuka, N., Kurita, N., Nakamagoe, K., Tamaoka, A., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20101623 · Cited by 34
“Loss of function in DAP12 or TREM-2 as a result of mutations in the TYROBP gene or TREM2 gene, respectively, is responsible for a recessive genetic disorder named Nasu-Hakola disease or polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (Paloneva et al., 2000, 2002).”
BackgroundCerebrospinal fluid neurogranin and TREM2 in Huntington’s disease
Byrne, L. M., Rodrigues, F. B., Johnson, E. B., Vita, E. D., Blennow, K., Scahill, R. I., Zetterberg, H., Heslegrave, A., & Wild, E. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-21788-x · Cited by 32
“However, with age included as a covariate, the differences were no Group (n) Control (12) HD (20) Age 40 (25) 54 (13) Sex F/M 3/9 9/11 CAG N/A 44 (4) DBS N/A 401 (127) Total functional capacity N/A 11 (3) UHDRS Total motor score N/A 26 (24) Neurogranin (pg/mL) 40.5 (100.5; 10–282) 43.5 (72.5; 10–392) Table 1.”
BackgroundInfluentialKorvatska, O., Kiianitsa, K., Ratushny, A., Matsushita, M., Beeman, N., Chien, W.-M., Satoh, J.-I., Dorschner, M. O., Keene, C. D., Bammler, T. K., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.559342 · Cited by 33
“In PLOSL, mutations that inactivate TREM2, including premature stop codons (49, 50), splice-site mutations (22, 51), and the missense variants D134G, K186N (4), Y38C, T66M, and V126G (5, 52, 53), have a recessive mode of inheritance.”
BackgroundMethodSelf-citationContributions of triggering-receptor-expressed-on-myeloid-cells-2 to neurological diseases
Han, J., Wang, M., Ren, M., & Lou, H. (2017) · International Journal of Neuroscience · doi:10.1080/00207454.2016.1264072 · Cited by 30
Elliott, R., Li, F., Dragomir, I., Chua, M. M. W., Gregory, B. D., & Weiss, S. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075346 · Cited by 29
“In humans, congenital natural polymorphisms that cause loss of function mutations in either TREM2 or DAP12 result in Nasu-Hakola disease, which is characterized by late-onset demyelination in the CNS and osteopetrosis [27-30].”
BackgroundThe Microglial Response to Neurodegenerative Disease
Song, W. M., & Colonna, M. (2018) · Advances in immunology · doi:10.1016/bs.ai.2018.04.002 · Cited by 30
Phosphorylated Syk expression is enhanced in Nasu‐Hakola disease brains
Satoh, J., Tabunoki, H., Ishida, T., Yagishita, S., Jinnai, K., Futamura, N., Kobayashi, M., Toyoshima, I., Yoshioka, T., Enomoto, K., et al. (2012) · Neuropathology · doi:10.1111/j.1440-1789.2011.01256.x · Cited by 30
“Currently, 17 different loss-of-function mutations are identified in either DAP12 or TREM2, all of which cause an identical disease phenotype.(5,6) The trimolecular complex composed of TREM2 monomer and DAP12 homodimer constitutes a receptor/”
BackgroundLipid in microglial biology — from material to mediator
Yamamoto, S., & Masuda, T. (2023) · Inflammation and Regeneration · doi:10.1186/s41232-023-00289-z · Cited by 28
“TREM2 is known as an extracellular lipid sensor [5] and mediates myelin debris clearance [43], and the amino acid polymorphisms of Trem2 cause neurological disorders, such as Alzheimer’s disease and Nasu-Hakola disease [18, 19, 24, 41], although the precise mechanisms by which the mutation causes a neurodegenerative p…”
BackgroundImpaired Fracture Healing Caused by Deficiency of the Immunoreceptor Adaptor Protein DAP12
Kamimura, M., Mori, Y., Sugahara–Tobinai, A., Takai, T., & Itoi, E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128210 · Cited by 31
A novel mutation in the CSF1R gene causes a variable leukoencephalopathy with spheroids
Piana, R. L., Webber, A., Guiot, M., Cortes, M. D. P., & Brais, B. (2014) · Neurogenetics · doi:10.1007/s10048-014-0413-1 · Cited by 32
“The presence of bone cysts is associated with leukoencephalopathy in patients with PLOSL, which are due to mutations in the TYROBP or TREM2 genes [14, 15].”
Brain Calcifications in Adult-Onset Genetic Leukoencephalopathies: A Review
Ayrignac, X., Nicolas, G., Dalliere, C. C., Hannequin, D., & Labauge, P. M. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.1062 · Cited by 29
TREM2 in Neurodegenerative Disorders: Mutation Spectrum, Pathophysiology, and Therapeutic Targeting
Yang, H.-W., Kim, D., Yang, Y., Bagyinszky, E., & An, S. S. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157057 · Cited by 28
Necroptosis and Neuroinflammation in Retinal Degeneration
Tao, Y., Murakami, Y., Vavvas, D. G., & Sonoda, K. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.911430 · Cited by 29
“Triggeringreceptors-expressed-on-myeloid-cells 2 (TREM2) is one kind of microglial receptor that is highly expressed in anti-inflammatory or pro-regenerative microglia and involved in phagocytosis and immune regulation (Paloneva et al., 2002; Hickman and El Khoury, 2014; Hickman et al., 2018).”
BackgroundZhu, B., Feng, J., Liang, X., Fu, Z., Liao, M., Deng, T., Wang, K., Xie, J., Chi, J., Yang, L., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02538-1 · Cited by 27
“TREM2 has been shown to play a vital role in cognitive-related neuroprotection in multiple diseases, such as nonalcoholic fatty liver disease [9], postoperative cognitive impairment [10], Nasu-Hakola disease [11], vascular dementia [12], and Alzheimer ’ s disease (AD) [13, 14].”
Mallach, A., Gobom, J., Zetterberg, H., Hardy, J., Piers, T. M., Wray, S., & Pocock, J. M. (2021) · Brain Communications · doi:10.1093/braincomms/fcab009 · Cited by 28
“, 2013), whilst homozygous missense TREM2 mutations such as T66M cause Nasu-Hakola disease, a rare early-onset dementia with bone cysts (Paloneva et al., 2002; Guerreiro et al., 2013).”
BackgroundProteomic studies of cerebrospinal fluid biomarkers of Alzheimer’s disease: an update
Portelius, E., Brinkmalm, G., Pannee, J., Zetterberg, H., Blennow, K., Dahlén, R., Brinkmalm, A., & Gobom, J. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1384697 · Cited by 28
“Mutations in the TREM2 gene have been shown to be associated with an autosomal recessive form of early-onset dementia called Nasu–Hakola disease [87].”
BackgroundThe evolution of microglia replacement: A new paradigm for CNS disease therapy
Rao, Y., Bai, Y., Li, X., Du, B., & Peng, B. (2025) · Cell stem cell · doi:10.1016/j.stem.2025.10.014 · Cited by 27
Ibach, M., Mathews, M., Linnartz‐Gerlach, B., Theil, S., Kumar, S., Feederle, R., Brüstle, O., Neumann, H., & Walter, J. (2020) · Glia · doi:10.1002/glia.23953 · Cited by 26
“However, TREM2 associates with its adaptor protein DAP12 (DNAX activation protein of 12 kDa, TYROBP) via interactions of charged residues within the transmembrane domains of both proteins (Paloneva et al., 2002).”
BackgroundKiianitsa, K., Kurtz, I., Beeman, N. E., Matsushita, M. M., Chien, W., Raskind, W. H., & Korvatska, O. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.2hi0720-463rr · Cited by 26
Distinct Microglial Responses in Two Transgenic Murine Models of TAU Pathology
Romero-Molina, C., Navarro, V., Sanchez-Varo, R., Jimenez, S., Fernandez-Valenzuela, J. J., Sanchez-Mico, M. V., Muñoz-Castro, C., Gutierrez, A., Vitorica, J., & Vizuete, M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00421 · Cited by 27
“Moreover, deficiencies in TREM2 are also associated with rare hereditary neurodegenerative diseases (Paloneva et al., 2002; Chitu et al., 2016).”
BackgroundYoung-Onset Dementia: A Practical Approach to Diagnosis
Ridha, B. H., & Josephs, K. A. (2006) · The Neurologist · doi:10.1097/01.nrl.0000186798.86255.69 · Cited by 27
“The association with pyramidal features suggests VaD, other causes of stroke (see below), AD with cotton wool plaques typically associated with deletions in exon 9 of presenilin-1 gene,(95) multiple sclerosis,(40) vitamin B12 deficiency,(76) SCA 1, 3, and 17,(68) NIA,(65) mitochondrial disease,(90) Fahr disease,(63) e…”
BackgroundInfluentialTREM2 in Neurodegenerative Diseases: Mechanisms and Therapeutic Potential
Li, L., Zheng, X., Ma, H., Zhu, M., Li, X., Sun, X., & Feng, X. (2025) · Cells · doi:10.3390/cells14171387 · Cited by 25
“The significance of TREM2 was initially revealed through the discovery of the fact that biallelic loss-of-function mutations cause Nasu–Hakola disease (NHD), a rare autosomal recessive disorder characterized by early-onset dementia and bone lesions [47–49].”
Luo, L., Chen, J., Wu, Q., Yuan, B., Hu, C., Yang, T., Wei, H., & Li, T. (2023) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2023.104090 · Cited by 25
Fenoglio, C., Galimberti, D., Piccio, L. M., Scalabrini, D., Panina‐Bordignon, P., Buonsanti, C., Venturelli, E., Lovati, C., Forloni, G., Mariani, C. B., et al. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.10.029 · Cited by 29
Mao, Q., Wang, D., Li, Y., Kohler, M., Wilson, J., Parton, Z., Shmaltsuyeva, B., Gursel, D., Rademakers, R., Weintraub, S., et al. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx085 · Cited by 24
Toyabe, S., Kaneko, U., & Uchiyama, M. (2004) · Journal of Autoimmunity · doi:10.1016/j.jaut.2004.09.003 · Cited by 24
Synaptic pruning by microglia: lessons from genetic studies in mice
de Deus, J. L., Faborode, O. S., & Nandi, S. (2024) · Developmental Neuroscience · doi:10.1159/000541379 · Cited by 23
Trem2-deficiency aggravates and accelerates age-related myelin degeneration
McCray, T. J., Bedford, L. M., Bissel, S. J., & Lamb, B. T. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01855-3 · Cited by 23
“TREM2 activity is linked to a variety of diseases that display white matter-pathology such as Nasu-Hakola disease (NHD), frontotemporal lobar degeneration (FTLD), and multiple sclerosis (MS) [3, 10, 37, 50].”
BackgroundGopalakrishna, P. K., Nassir, C. M. N. C. M., Anandan, S., Hussan, F., Dandala, K. C. R., Sura, S., Jagadeesan, S., Moklas, M. A. M., Vishnumukkala, T., & Hein, Z. M. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-026-01671-4 · Cited by 25
“TREM2 variants are associated with rare disorders such as Nasu–Hakola disease and confer increased susceptibility to late-onset AD (LOAD) (Paloneva et al. 2002 ).”
Basha, S. C., Ramaiah, M. J., & Rao, K. S. J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221070 · Cited by 24
“Even mutations in early stop codons [37] or splice sites [38] may result in NHD and FTD.”
BackgroundInfluentialYanaizu, M., Sakai, K., Tosaki, Y., Kino, Y., & Satoh, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-25204-2 · Cited by 24
Loss of USP18 in microglia induces white matter pathology
Schwabenland, M., Mossad, O., Peres, A. G., Kessler, F., Maron, F. J. M., Harsan, L.-A., Bienert, T., von Elverfeldt, D., Knobeloch, K.-P., Staszewski, O., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0757-8 · Cited by 20
An Alternatively Spliced TREM2 Isoform Lacking the Ligand Binding Domain is Expressed in Human Brain
Shaw, B. C., Snider, H. C., Turner, A. K., Zajac, D. J., Simpson, J. F., & Estus, S. (2022) · Journal of Alzheimer's Disease · doi:10.3233/jad-215602 · Cited by 23
“Exon 3 skipping has been previously described in two small cohorts [3, 22].”
BackgroundKiialainen, A., Veckman, V., Saharinen, J., Paloneva, J., Gentile, M., Hakola, P., Hemelsoet, D., Ridha, B. H., Kopra, O., Julkunen, I., et al. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0191-4 · Cited by 30
“Three of the patients were homozygotes for a deletion encompassing exons 1–4 of the DAP12 gene, also known as the PLOSLFin mutation [3], and two of the patients were homozygotes for point mutations in TREM2, one resulting in a premature stop codon (Q33Stp) and the other leading to an amino acid substitution (V126G) [4…”
BackgroundMethodSelf-citationVarnum, M. M., Clayton, K. A., Yoshii-Kitahara, A., Yonemoto, G., Koro, L., Ikezu, S., & Ikezu, T. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.759159 · Cited by 22
Emerging Roles of Cells and Molecules of Innate Immunity in Alzheimer’s Disease
Tamburini, B., Badami, G. D., Manna, M. P. L., Azgomi, M. S., Caccamo, N., & Dieli, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511922 · Cited by 25
The Birth of the Modern Era of Parkinson’s Disease Genetics
Singleton, A., Hardy, J., & Gasser, T. (2017) · Journal of Parkinson s Disease · doi:10.3233/jpd-179009 · Cited by 22
“In thinking back over the sheer scale of work and effort that we and others placed in this area, it is perhaps surprising that only a small number of genes were identified for PD during this time; however, the influence of these findings was great.”
Backgroundvon Saucken, V. E., Jay, T. R., & Landreth, G. E. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105072 · Cited by 23
“, 2013) and are associated with several other neurodegenerative diseases (Paloneva et al., 2002; Rayaprolu et al., 2013).”
Evaluation of the Common Molecular Basis in Alzheimer’s and Parkinson’s Diseases
Rana, P., Franco, E. F., Rao, Y., Syed, K., Barh, D., Azevedo, V., Ramos, R. T. J., & Ghosh, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153730 · Cited by 22
“Studies found the mutation in TREM2 is related to an autosomal recessive form of dementia [45].”
BackgroundThe genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2
Bianchin, M. M., Lima, J. E., Natel, J., & Sakamoto, A. C. (2006) · Neurology · doi:10.1212/01.wnl.0000216105.11788.0f · Cited by 22
Self-citationPathways linking Alzheimer’s disease risk genes expressed highly in microglia
Hodges, A. K., Piers, T. M., Collier, D., Cousins, O., & Pocock, J. M. (2021) · Neuroimmunology and Neuroinflammation · doi:10.20517/2347-8659.2020.60 · Cited by 21
“variants affecting both alleles primarily alter protein structure, cell surface expression and shedding, and cause Nasu-Hakola disease([115,216,219]).”
Genome research in pre-dementia stages of Alzheimer's disease
Moreno–Grau, S., & Ruiz, A. (2016) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2016.12 · Cited by 22
Jansen, M. I., Broome, S. T., & Castorina, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094788 · Cited by 21
Brain macrophages in vascular health and dysfunction
Bijnen, M., Sridhar, S., Keller, A., & Greter, M. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.11.012 · Cited by 21
Inclusion Body Myopathy with Paget Disease of Bone and/or Frontotemporal Dementia
Kimonis, V. E. (2007) · eScholarship (California Digital Library) · Cited by 21
Giuliano, S., Agresta, A. M., Palma, A. D., Viglio, S., Mauri, P., Fumagalli, M., Iadarola, P., Montalbetti, L., Salvini, R., & Bardoni, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110073 · Cited by 23
“NHD has been demonstrated to rise from a structural defect in the DNAX-activating protein 12 gene (DAP12 gene, also called TYROBP, for tyrosine-kinase binding protein) or in the Triggering Receptor Expressed on Myeloid cells 2 (TREM 2) gene, the two genes encoding for different subunits of the same membrane receptor s…”
BackgroundJayadev, S. (2022) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001125 · Cited by 22
Bock, V., Botturi, A., Gaviani, P., Lamperti, E., Maccagnano, C., Piccio, L. M., Silvani, A., & Salmaggi, A. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.01.021 · Cited by 24
Self-citationFrontotemporal Dementia and Chorea Associated with a Compound Heterozygous TREM2 Mutation
Redaelli, V., Salsano, E., Colleoni, L., Corbetta, P., Tringali, G., Sole, A. D., Giaccone, G., & Rossi, G. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180018 · Cited by 20
“TREM2 homozygous mutations had been previously disclosed in cases of the auto-somic recessive Nasu-Hakola disease, also known as polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy [5].”
The Role of Microglia in Inherited White-Matter Disorders and Connections to Frontotemporal Dementia
Sirkis, D. W., Bonham, L. W., & Yokoyama, J. S. (2021) · The Application of Clinical Genetics · doi:10.2147/tacg.s245029 · Cited by 18
TREM2 variants that cause early dementia and increase Alzheimer’s disease risk affect gene splicing
Kiianitsa, K., Lukes, M. E., Hayes, B. J., Brutman, J. N., Valdmanis, P. N., Bird, T. D., Raskind, W. H., & Korvatska, O. (2024) · Brain · doi:10.1093/brain/awae014 · Cited by 21
Self-citationAdult onset leukodystrophy with neuroaxonal spheroids and demyelinating plaque‐like lesions
Martínez-Sáez, E. A., Shah, S., Costa, C., Fleminger, S., Connor, S. E. J., & Bódi, I. (2011) · Neuropathology · doi:10.1111/j.1440-1789.2011.01257.x · Cited by 19
“However, screening for DAP12 (TYROBP) and TREM2 (Nasu-Hakola disease) and eIF2B (vanishing white matter disease) may be considered depending on the clinical setting.(36) Discovery of the genetic aetiology in the future may help family counselling in inherited cases.”
BackgroundChen, Y., Chen, X., Guo, X., Song, W., Cao, B., Wei, Q., Ou, R., Zhao, B., & Shang, H. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2279-x · Cited by 20
“that is characterized by bone cysts and early-onset progressive dementia [2].”
BackgroundLi, K., Ran, B., Wang, Y., Liu, L., & Li, W. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.999061 · Cited by 18
“TREM2 is a microglia type I transmembrane protein that is a member of the immunoglobulin superfamily (Paloneva et al., 2002; Yeh et al., 2017; Kulkarni et al., 2021) and has been identified as an immuneassociated receptor with high AD risk gene expression (Guerreiro et al.”
BackgroundNiche-specific therapeutic targeting of myeloid cells in the central nervous system
Frosch, M., & Prinz, M. (2025) · Immunity · doi:10.1016/j.immuni.2025.03.016 · Cited by 20
Microglial phagocytosis in epilepsy: Mechanisms and impact
Barath, A. S., & Wu, L. (2025) · The Journal of Physiology · doi:10.1113/jp288573 · Cited by 18
“Mutations in TREM2 and its adaptor protein TYROBP have been identified as the causes of Nasu-Hakola disease, a neurodegenerative disease commonly presenting with seizures (Paloneva et al., 2000; Paloneva et al., 2001; Paloneva et al., 2002).”
Allogenic microglia replacement: A novel therapeutic strategy for neurological disorders
Rao, Y., & Peng, B. (2023) · Fundamental Research · doi:10.1016/j.fmre.2023.02.025 · Cited by 20
“Mutations in TREM2 or the downstream TYROBP, the gene encoding DAP12, cause Nasu-Hakola disease (NHD) or polycystic lipomem-branous osteodysplasia with sclerosing leukoencephalopathy (PLOSL) [ 31 , 32 ].”
BackgroundInhibiting CSF1R alleviates cerebrovascular white matter disease and cognitive impairment
Askew, K. E., Beverley, J., Sigfridsson, E., Szymkowiak, S., Emelianova, K., Dando, O., Hardingham, G. E., Duncombe, J., Hennessy, E., Koudelka, J., et al. (2023) · Glia · doi:10.1002/glia.24481 · Cited by 20
“The degenerative ‘ microgliopathies ’ , resulting from mutations in microglial-enriched genes (e.g., TREM2 , TYROBP , CSF1R , NRROS ) are notable for predominantly affecting white matter (Oosterhof et al., 2019; Paloneva et al., 2002; Smith et al., 2020).”
BackgroundDAP12 interacts with RER1 and is retained in the secretory pathway before assembly with TREM2
Liu, Y., Theil, S., Ibach, M., & Walter, J. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05298-w · Cited by 18
Errichiello, E., Dardiotis, E., Mannino, F., Paloneva, J., Mattina, T., & Zuffardi, O. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01685 · Cited by 18
“Despite the well-researched role of TREM2 and TYROBP/DAP12 in immunity, immunological phenotypes have never been reported in NHD patients.”
BackgroundSelf-citationXiao-dong, T., Liu, Z., Zhang, Y., & Zhang, X. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120049 · Cited by 18
Pepłońska, B., Berdyński, M., Mandecka, M., Barczak, A. K., Kuźma‐Kozakiewicz, M., Barcikowska, M., & Żekanowski, C. (2018) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2018.1451894 · Cited by 20
“Homozygous loss-of-function mutations in TREM2 were described for the first time as a cause of the rare autosomal recessive Nasu-Hakola disease (polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy and presenile dementia) (3,4).”
BackgroundMonoallelic TYROBP deletion is a novel risk factor for Alzheimer’s disease
Martiskainen, H., Willman, R.-M., Harju, P., Heikkinen, S., Heiskanen, M., Müller, S. A., Sinisalo, R., Takalo, M., Mäkinen, P. M., Kuulasmaa, T., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00830-3 · Cited by 18
“NHD is a rare recessive neurodegenerative disorder characterized by bone cysts and pathological fractures at early adulthood, followed by early-onset frontotemporal type dementia and death at the middle age [3, 4].”
Bianchin, M. M., & Snow, Z. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.06.032 · Cited by 18
Self-citationSu, W., Shi, Z., Liu, S., Wang, X., Liu, S., & Ji, Y. (2018) · Annals of Human Genetics · doi:10.1111/ahg.12241 · Cited by 16
Linkage analysis of schizophrenia controlling for population substructure
Paunio, T., Arajärvi, R., Terwilliger, J. D., Hiekkalinna, T., Haimi, P., Partonen, T., Lönnqvist, J. K., Peltonen, L., & Varilo, T. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30905 · Cited by 16
“…itself is not the most associated outside Finland, the same gene or even the genes on the same metabolic pathway may harbor additional variation in other populations, as geneticists have elucidated for numerous other disorders [Paloneva et al., 2002; Kytt€al€a et al., 2006; Tallila et al., 2008].”
BackgroundSelf-citationKinoshita, M., Oyanagi, K., Kondo, Y., Ishizawa, K., Ishihara, K., Yoshida, M., Inoue, T., Mitsuyama, Y., Yoshida, K., Yamada, M., et al. (2021) · eNeurologicalSci · doi:10.1016/j.ensci.2021.100310 · Cited by 21
“Patient #3 was diagnosed as having ALSP by neuropathological examination [37], but did not carry any mutation in CSF1R, triggering receptor expressed on myeloid cells 2 (TREM2) or DNAX-activating protein 12 (DAP12), which are causative genes of Nasu-Hakola disease [54,55].”
BackgroundCSTA plays a role in osteoclast formation and bone resorption by mediating the DAP12/TREM2 pathway
Wei, R., Zhang, L., Hu, W., Wu, J., & Zhang, W. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.08.033 · Cited by 18
Tambini, M. D., & D’Adamio, L. (2020) · Scientific Reports · doi:10.1038/s41598-020-60800-1 · Cited by 17
Kober, D. L., Wanhainen, K. M., Johnson, B. M., Randolph, D. T., Holtzman, M. J., & Brett, T. J. (2014) · Protein Expression and Purification · doi:10.1016/j.pep.2014.01.015 · Cited by 16
“The major mutations associated with NHD produce premature termination of TREM-2 protein and are also phenocopied by deletion of DAP12.”
BackgroundZhang, Y., Shi, Y., Wang, L., Zhao, L., Wang, Y., Yan, J., Sun, X., Luo, Q., & Li, L. (2025) · British Journal of Pharmacology · doi:10.1111/bph.17475 · Cited by 15
“Mutations in TREM2 or its associated adapter protein, DNAX-activating protein of 12 kDa, result in Nasu-Hakola disease, which is characterized by progressive neurodegeneration and extensive demyelination in subcortical white matter (Paloneva et al., 2002).”
The multicellular interplay of microglia in health and disease: lessons from leukodystrophy
Berdowski, W. M., Sanderson, L. E., & van Ham, T. J. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048925 · Cited by 15
“TREM2 is a transmembrane receptor and DAP12/TYROBP a transmembrane adaptor protein that together form a signaling complex (Deczkowska et al., 2020; Ulland and Colonna, 2018).”
BackgroundInfluentialRole of triggering receptor expressed on myeloid cells 2 (TREM2) in neurodegenerative dementias
Shafi, S., Singh, A., Ibrahim, A. M., Alhajri, N., Izneid, T. A., & Pottoo, F. H. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15215 · Cited by 15
“All of these persons carried a point mutant that is suggested to result in a truncated TREM2 protein or a particular amino acid switch in the transmembrane domain resulting in dysfunction of TREM2 to bind DAP12 (Paloneva et al., 2002; Soragna et al., 2003).”
BackgroundInfluentialWang, T., Liu, X., Wang, X., Hua, F., & Yan, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1739875 · Cited by 14
TREM2 variants as a possible cause of frontotemporal dementia with distinct neuroimaging features
Samanci, B., Bilgiç, B., Gelişin, Ö., Tepgeç, F., Guven, G., Tüfekçioğlu, Z., Alaylıoğlu, M., Hanagasi, H. A., Gürvit, H., Guerreiro, R., et al. (2021) · European Journal of Neurology · doi:10.1111/ene.14908 · Cited by 14
“Mutations in two genes, triggering receptor expressed on myeloid 15 cells-2 (TREM2) [4-15] (Supplementary Table) and tyrosine kinase-binding protein 16 (TYROB, also known as DAP12), have been associated with NHD.”
BackgroundAstroski, J. W., Akporyoe, L. K., Androphy, E. J., & Custer, S. K. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.01.003 · Cited by 14
Role of TREM2 in immune and neurological diseases: Structure, function, and implications
Yin, P., Su, Z., Shu, X., Dong, Z., & Tian, Y. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113286 · Cited by 16
Sanchez-Molina, P., Almolda, B., Benseny‐Cases, N., González, B., Perálvarez‐Marín, A., & Castellano, B. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.03.015 · Cited by 14
Boudesco, C., Nonneman, A., Cinti, A., Picardi, P., Redaelli, L., Swijsen, S., Roewe, J., Reinhardt, P., Ibach, M., Walter, J., et al. (2022) · Glia · doi:10.1002/glia.24252 · Cited by 15
“human genetic studies identified that loss of function mutations in either TREM2 or its accessory protein DAP12 were causative for Nasu-Hakola disease and frontal temporal dementia (Guerreiro et al., 2013; Paloneva et al., 2002).”
BackgroundRole of TREM2 in the Development of Neurodegenerative Diseases After Traumatic Brain Injury
Zhang, C., & Chen, S. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03094-w · Cited by 14
Impact of aging on gene expression response to x-ray irradiation using mouse blood
Broustas, C. G., Duval, A. J., & Amundson, S. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-89682-7 · Cited by 14
Chen, X., Chen, Y., Wei, Q., Guo, X., Cao, B., Ru⁃wei, O., Zhao, B., & Shang, H. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.05.010 · Cited by 15
“Q33X) are responsible for Nasu-Hakola disease [2–4], a rare autosomal-recessive disease that is characterized by bone cysts and early-onset progressive dementia [5].”
BackgroundAssessing campsite conditions for limits of acceptable change management in Shenandoah National Park
Williams, P. W., & Marion, J. L. (1995) · Cited by 19
Brain–Bone Axis in Physiological and Pathological Conditions
Massaccesi, L., Romanelli, M. M. C., & Galliera, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199822 · Cited by 14
“Consequently, this disruption of the proper TREM2/DAP12 signaling pathway affects both the CNS and osteoclasts, leading to a cascade of neurological and clinical bone manifestations [57,58].”
Lipomembranous fat necrosis: A distinctive and unique morphology (Review)
Matsukuma, S., Matsunaga, A., Takahashi, O., & Ogata, S. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11695 · Cited by 13
A novel compound heterozygous mutation in the DAP12 gene in a patient with Nasu-Hakola disease
Kuroda, R., Satoh, J., Yamamura, T., Anezaki, T., Terada, T., Yamazaki, K., Obi, T., & Mizoguchi, K. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.09.019 · Cited by 13
“1 [2–5].”
BackgroundAlternatives to amyloid for Alzheimer's disease therapies—a symposium report
Cable, J., Holtzman, D. M., Hyman, B. T., Tansey, M. G., Colonna, M., Kellis, M., Brinton, R. D., Albert, M., Wellington, C. L., Sisodia, S. S., et al. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14371 · Cited by 13
Leukoencephalopathy with neuroaxonal spheroids presenting as frontotemporal dementia.
Levin, N., Soffer, D., Biran, I., Gomori, J. M., Bocher, M., Blumen, S. C., Abramsky, O., Segal, R., & Lossos, A. (2008) · PubMed · Cited by 13
Katsumoto, A., Kokiko‐Cochran, O. N., Bemiller, S. M., Xu, G., Ransohoff, R. M., & Lamb, B. T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.978423 · Cited by 12
“Homozygous mutations in either TREM2 or its adapter protein DNAX-activating protein of 12 kDa (DAP12) result in Nasu-Hakola disease (NHD), a progressive neurodegenerative disorder with massive gliosis and demyelination in the subcortical white matter (12, 13).”
BackgroundMaderna, E., Visoná, S. D., Bolcato, V., Redaelli, V., Caroppo, P., Montalbetti, L., Giaccone, G., & Osculati, A. M. M. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-201085 · Cited by 12
Fong, L., Chalkley, M. J., Tan, S. K., Grabe, M., & DeGrado, W. F. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2026318118 · Cited by 12
Zhou, W., Zhou, Y., & Li, J. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12103589 · Cited by 12
“Homozygous loss-of-function mutations in TREM2 is associated with an autosomal recessive form Nasu–Hakola disease that is characterized by early onset dementia, bone cysts and consequent fractures [8].”
BackgroundMicroglia in Alzheimer’s Disease: A Favorable Cellular Target to Ameliorate Alzheimer’s Pathogenesis
Sumsuzzman, D. M., Uddin, M. S., Kabir, M. T., Hasana, S., Perveen, A., Alanazi, I. S., Albadrani, G. M., Abdel‐Daim, M. M., & Ashraf, G. M. (2022) · Mediators of Inflammation · doi:10.1155/2022/6052932 · Cited by 12
Nasu-Hakola disease: a rare entity in Italy. Critical review of the literature.
Montalbetti, L., Soragna, D., Ratti, M. T., Bini, P., Buscone, S., & Moglia, A. (2004) · PubMed · Cited by 12
Kimura, T., Ishizawa, K., Mitsufuji, T., Abe, T., Nakazato, Y., Yoshida, K., Sasaki, A., & Araki, N. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12046 · Cited by 12
Updates on Tau-Related Drug Targets and Potential Disease-Modifying Therapies for Alzheimer Disease
Djurovic-Topalovic, A., Horgan, N. G., & Fortin, J. S. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.05.020 · Cited by 12
Clearing Your Mind: Mechanisms of Debris Clearance After Cell Death During Neural Development
Liu, K. E., Raymond, M. H., Ravichandran, K. S., & Kucenas, S. (2022) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-110920-022431 · Cited by 12
Headmasters: Microglial regulation of learning and memory in health and disease
Weinhard, L., d’Errico, P., & Tay, T. L. (2018) · AIMS molecular science · doi:10.3934/molsci.2018.1.63 · Cited by 12
“In humans, recessive genetic mutations in DAP12 or TREM2 ( Triggering Receptor Expressed On Myeloid Cells 2 ) [84–86] are responsible for the microgliopathy Nasu-Hakola disease (NHD), a rare inherited neuropsychiatric condition characterized by early dementia, formation of bone cysts and premature…”
Frontotemporal dementia presentation in patients with heterozygous p.H157Y variant of TREM2
Ogonowski, N. S., Santamaría‐García, H. A., Báez, S., López, A., Laserna, A., Garcia-Cifuentes, E. R., Ayala‐Ramírez, P., Zarante, I., Suárez‐Obando, F., Reyes, P. A., et al. (2023) · Journal of Medical Genetics · doi:10.1136/jmg-2022-108627 · Cited by 12
Metadata
- Authors
- Paloneva, J., Manninen, T., Christman, G., Hovanes, K., Mandelin, J., Adolfsson, R., Bianchin, M., Bird, T., Miranda, R., Salmaggi, A., Tranebjærg, L., Konttinen, Y., & Peltonen, L.
- Affiliations
- University of Helsinki (FI)
- University of California, Los Angeles (US)
- Umeå University (SE)
- University of Washington (US)
- Hospital Universitario La Paz (ES)
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- Bispebjerg Hospital (DK)
- Helsinki University Hospital (FI)
- Corresponding author
- Peltonen, Leena
- ORCID
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2002-09
- Volume
- 71
- Issue
- 3
- Pages
- 656-662
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC379202
- OpenAlex
- W2014200126
- Cited by
- 683
- References
- 29
- Citations by year
- 2026: 28 · 2025: 32 · 2024: 27 · 2023: 35 · 2022: 37 · 2021: 48 · 2020: 47 · 2019: 34 · 2018: 54 · 2017: 53 · 2016: 38 · 2015: 42 · 2014: 29 · 2013: 28 · 2012: 11
- FWCI
- 6.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 3974 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Lastentautien Tutkimussäätiö
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Nasu-Hakola disease, TREM2, TYROBP, DAP12, receptor signaling complex, genetic heterogeneity, progressive dementia, bone cysts, recessive inheritance
- MeSH terms
- Triggering Receptor Expressed on Myeloid Cells-1, Actins, Female, Haplotypes, Humans, Male, Membrane Glycoproteins, Membrane Proteins, Molecular Sequence Data, Mutation, Pedigree, Phenotype, Receptors, Immunologic, RNA, Messenger, Signal Transduction, Reverse Transcriptase Polymerase Chain Reaction, Gene Expression Profiling, Protein Subunits, Macromolecular Substances, Adaptor Proteins, Signal Transducing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.